Keith Ignotz
MBA President & CEO
Over 30 years in leading executive roles in medical device and pharma

CEO/Founder Freedom Meditech (Sold) CEO DiaKine Therapeutics (Sold) COO SpectRx (took public on NASDAQ) VP Allergan Humphrey, Division of Allergan (Sold)

Mark Byrne, Ph.D.
Founder, Chairman, & CTO

Distinguished/Endowed Chemical & Biomedical Engineering Professor
(PhD Purdue in Dr. Nicholas Peppas
Laboratories, BS Carnegie Mellon)

Internationally recognized leader in biomaterials, drug delivery, and ocular drug delivery with 20 years experience (Auburn and Rowan Universities, over 100 highly cited top journal publications and 14 patents )

Paul Byrne, MBA
Co-Founder, CBO & CFO

Over 25 years in leading executive roles at McKinsey & Company and PNC Bank (MBA Harvard)

Experience in corporate strategy, operations, distribution, sales, and management consulting in pharma and healthcare

Frederick Cahn, Ph.D.
Acting CRO

Over 30 years of experience in regulatory and medical product development and consulting

Led successful FDA approval of multiple technologies in pharma and medical devices

Scientific Advisory Board

Steve Martin  Advisory Board
Prior Founder of CIBA Vision Optics (now part of Alcon) and CIBA Vision Ophthalmics (now part of Novartis). At CIBA, he and his team grew sales to over
$1.2 Billion and led >6,000 employees.

Lynn Winterton, Ph.D. Scientific Advisory Board
Prior Global Head of R&D CIBA Vision, 30+yrs developing & commercializing multiple, successful contact lenses on market today

Paul Karpecki, O.D. Scientific Advisory Board
Chief Clinical Editor of Review of Optometry, 20+yrs Director of Corneal Surgery

Steve Hamilton, M.D. Clinical Advisor
Board Certified Ophthalmologist, 20+yrs specializing in corneal disease and surgery

Ron Dadino Regulatory Affairs
Prior J&J VP leading regulatory strategy for all combination products , 33+yrs in pharma & medical device sector, led global approval for first drug/stent combination device >$1B in sales

Gary Novack, Ph.D. Regulatory Affairs
President of PharmaLogic, 30+yrs in pharma R&D, consultant 400+ pharma
and medical device firms on regulatory strategy